Author
Listed:
- Brício Barbosa Ferreira
(Universidad Abierta Interamericana, Facultad de Medicina y Ciencias de la Salud. Argentina)
- Patricia Salguero
(Universidad Abierta Interamericana, Facultad de Medicina y Ciencias de la Salud. Argentina)
Abstract
Introduction: Autism spectrum disorder (ASD) is a neurobiological developmental disorder that affects a significant proportion of the pediatric population. Conventional pharmacological treatment does not always effectively alleviate behavioral and emotional symptoms. In this context, cannabidiol (CBD), a cannabis-derived compound, has been proposed as a therapeutic alternative. This article reviews the literature on the use of CBD in children with ASD and evaluates its efficacy and safety.Material and methods: A systematic review of clinical studies and reviews on the use of CBD in the treatment of ASD in pediatric population was performed. We selected studies published between 2018 and 2024 that reported on the effects of CBD on ASD symptoms, such as repetitive behavior, anxiety, and difficulties in social communication.Results: The studies included in this review showed promising results in reducing behavioral and emotional symptoms in children with ASD treated with CBD. However, we highlighted the need for more controlled research with larger samples and longer follow-ups to confirm these findings.Conclusion: CBD has therapeutic potential in the treatment of ASD symptoms, especially behavioral and emotional problems. Despite the positive preliminary results, further rigorous studies are required to establish clear guidelines for its use in clinical practice.
Suggested Citation
Handle:
RePEc:cwj:neurod:v:4:y:2025:id:210
DOI: 10.56294/neuro2025210
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:cwj:neurod:v:4:y:2025:id:210. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chabely Cruzata (email available below). General contact details of provider: https://neurodivergences.ar/index.php/neuro .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.